STAT3 and ovarian carcinoma: It was demonstrated that miR-29a-3p and miR-21-5p synergistically inhibit STAT3, regulate Treg/Th17 cells and induce an imbalance, creating an immunosuppressive microenvironment that promotes ovarian cancer progression and metastasis (53).